EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window






Stroke 28(12): 2539-2544

The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window

Background and purpose: This study was performed to assess the efficacy and the therapeutic window for the calmodulin antagonist trifluoperazine in experiments involving transient middle cerebral artery (MCA) occlusion. Methods: Male Wistar rats were subjected to transient (2 hours) MCA occlusion by an intraluminal filament technique. Trifluoperazine (5.0 mg cntdot kg-1) was injected intraperitoneally 5 minutes, 1 hour, or 2 hours after the induction of ischemia. Drug administration was repeated 24 hours after the first injection. Neurological scores and infarct volumes were evaluated at 48 hours of reperfusion. The effect of trifluoperazine on cortical blood flow was studied with continuous laser-Doppler flowmetry. Results: The median value of neurological scores in the control rats (n=7) was 3, while those in the treated groups were 1 (5-minute group; n=7, P<.05) and 2 (1-hour and 2-hour groups; each n=7). The percentage of infarct volume in the control rats was 34.8 +- 4.9% (mean+-SD), while those in the treated groups were 11.3+-12.3% (5-minute group; P<.01), 24.8+-15.1% (1-hour group), and 28.8+-8.3% (2-hour group). Trifluoperazine, given at 5 minutes after ischemia, had no influence on blood flow in the neocortical penumbra during and after ischemia. Conclusions: The results demonstrate that trifluoperazine markedly reduces infarct volume after 2 hours of MCA occlusion when given 5 minutes after the induction of ischemia. However, the therapeutic window for trifluoperazine seems narrow since the drug had no significant effect when given after 1 or 2 hours.


Accession: 009546674

PMID: 9412646



Related references

Williams, A.J.; Dave, J.R.; Phillips, J.B.; Lin, Y.; McCabe, R.T.; Tortella, F.C., 2000: Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. Conantokin-G (Con-G), a 17-amino-acid peptide derived from marine snails and a potent N-methyl-D-aspartate (NMDA) antagonist, was evaluated for its neuroprotective properties in vitro and in vivo. In primary cerebellar neurons, Con-G was shown to...

Ueda, M.; Inaba, T.; Nito, C.; Kamiya, N.; Katayama, Y., 2014: Therapeutic impact of eicosapentaenoic acid on ischemic brain damage following transient focal cerebral ischemia in rats. Long-chain n-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA), have been shown to reduce ischemic neuronal injury. We investigated the effects of ethyl-EPA (EPA-E) on ischemic brain damage using a rat transient focal cerebral isc...

Arii, T.; Kamiya, T.; Arii, K.; Ueda, M.; Nito, C.; Katsura, K.I.; Katayama, Y., 2001: Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. Tacrolimus (FK506), an immunosuppressant currently used in clinic, is known to have neuroprotective properties. However, effects in focal ischemia are shown only in a endothelin induced middle cerebral artery (MCA) occlusion model or with filament...

Lou, M.; Eschenfelder, C.C.; Herdegen, T.; Brecht, S.; Deuschl, Günther., 2004: Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Background and Purpose: Hyperbaric oxygenation (HBO) is an attractive procedure that has been used frequently in cerebral ischemia. However, depending on the model of cerebral ischemia and HBO protocol, different and conflicting results were obtai...

Yanaka, K.; Spellman, S.R.; McCarthy, J.B.; Low, W.C.; Camarata, P.J., 1996: Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. II. Dose-response effect and the therapeutic window. The administration of massive doses of heparin has been demonstrated to reduce reperfusion injury. The authors have found that heparin's antileukocyte adhesion property may play a more important role than its anticoagulant property in prevent...

Shirasaki, Y.; Sato, T.; Morishima, Y., 2003: DY - 9760e, a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood - brain barrier permeability after transient focal ischemia. An alteration of the blood brain barrier (BBB) permeability contributes to the development of brain edema after stroke. In this study, we evaluated the effects of DY-9760e, a novel calmodulin antagonist, on brain edema formation and BBB integrity...

Sato, T.; Morishima, Y.; Sugimura, M.; Uchida, T.; Shirasaki, Y., 1999: DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. Perturbations in Ca2+ homeostasis have been proposed to lead to neuronal damage after cerebral ischemia. DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylethyl)-1H-indazole dihydrochloride 3.5 hydrate)...

Sato, T.; Morishima, Y.; Sugimura, M.; Uchida, T.; Shirasaki, Y., 1999: DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. Perturbations in Ca2+ homeostasis have been proposed to lead to neuronal damage after cerebral ischemia. DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylethyl)-1H-indazole dihydrochloride 3.5 hydrate)...

Ren, Yubo; Nowak, Thaddeus S.Jr.; Pulsinelli, William A., 1998: Therapeutic window for hypothermia after transient focal ischemia in spontaneously hypertensive rats. Stroke 29(1): 327, Jan

Margaill, I.; Parmentier, S.; Callebert, J.; Allix, M.; Boulu, R.G.; Plotkine, M., 1996: Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. The present study investigates the role of N-methyl-D-aspartate (NMDA) receptors in a model of transient focal cerebral ischemia in normotensive rats. The left middle cerebral artery and both common carotid arteries were occluded for 60 min. Preli...